SCHEMBL22988264

SCHEMBL22988264

CC(C)n1cc(-c2nc3c4cccc(Cl)c4nc(Cl)n3n2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.40
MAPT P10636 2/20 0.35
ADORA3 P0DMS8 4/20 0.34
ADORA2A P29274 3/20 0.34
ADORA1 P30542 3/20 0.34
THRB P10828 1/20 0.34
JAK2 O60674 1/20 0.33
NR4A2 P43354 1/20 0.32
CCNC P24863 3/20 0.32
CDK8 P49336 3/20 0.32
PDK2 Q15119 1/20 0.32
PIK3CD O00329 1/20 0.32
PIP5K1C O60331 1/20 0.32
PIK3CA P42336 1/20 0.32
PI4KA P42356 1/20 0.32
PIK3CG P48736 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
PDPK1 O15530 1/20 0.32
MAPK8 P45983 1/20 0.32
MAPK9 P45984 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393857 1.00 HSP90AB1 (0.40) HSP90AB1MAPTADORA3ADORA2AADORA1
SCHEMBL22988260 0.89 ABCB1 (0.35) ADORA3ADORA2AADORA1THRBJAK2
SCHEMBL22988085 0.89 ADORA3 (0.33) MAPTADORA3ADORA2AADORA1THRB
SCHEMBL30393354 0.87 ADORA2A (0.32) ADORA3ADORA2AADORA1JAK2PDK2
SCHEMBL22987630 0.87 PDK2 (0.36) ADORA3ADORA2AADORA1PDK2
SCHEMBL22987810 0.87 ADORA2A (0.32) ADORA3ADORA2AADORA1JAK2PDK2
SCHEMBL22987742 0.86 JAK2 (0.37) ADORA3ADORA2AADORA1JAK2
SCHEMBL30393118 0.86 PROKR1 (0.33) ADORA3ADORA2AADORA1JAK2
SCHEMBL22987815 0.86 PROKR1 (0.33) ADORA3ADORA2AADORA1JAK2
SCHEMBL22979975 0.85 HSP90AB1 (0.42) HSP90AB1MAPTADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 HSP90AB1 2893/4885MAPT 4047/4885ADORA3 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.